Lipari Foods subsidiary JLM Manufacturing recalled walnut, hazelnut, and cashew products because labels did not declare major allergens.
What happened
FDA cites three recalls that followed retail-store complaints about products made by Lipari's subsidiary JLM Manufacturing in August and September 2023. The recalled products contained walnuts, filberts/hazelnuts, or cashews that were not declared on the finished product labels. FDA also found that the firm's allergen controls at packaging and labeling were not adequate to prevent undeclared allergens.
What FDA found
The labels for the recalled walnut, hazelnut, and cashew products did not declare the major food allergen on the finished product label.
section 403(w) of the Act [21 U.S.C. § 343(w)]The firm did not identify and implement allergen preventive controls at packaging and labeling to prevent undeclared allergens.
21 CFR 117.135(a)(1) and (c)(2)The firm's subsidiary did not comply with the CGMP and preventive controls rule for human food.
21 CFR Part 117, Subparts A, C, D, E, F, and G; section 301(uu) [21 U.S.C. § 331(uu)]
What FDA wants
FDA tells Lipari to take prompt action to correct the violations and to notify FDA in writing within 15 working days of steps taken, including how it will prevent recurrence and supporting documents. If it cannot finish within 15 working days, it must explain the delay and give a completion date.
Who should pay attention
- food manufacturers that package nuts or other major allergens
- brands that rely on co-manufacturers or subsidiaries for labeling
- retailers and distributors that sell recalled or private-label foods
This is a summary. Read the original letter on fda.gov.